Drugs / AD-303A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07490327 | Apr → Sep 2026 overdue | androgenetic alopecia | Moogene Medi Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD-303A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07490327 ↗ |
| Route | Topical | “Topical AD-303A applied to the scalp according to the study protocol.” NCT07490327 ↗ |